Join
Live feed
·
PRReleasevia Quantisnow
Voyager Therapeutics Inc. logo

Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach

ByQuantisnow·Wall Street's wire, on your screen.
VYGR· Voyager Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYGR (Voyager Therapeutics Inc.) and more on Quantisnow.